Associated Papers
Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
Talaverón-Rey M et al.
Orphanet Journal of Rare Diseases, 2023
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
Álvarez-Córdoba M et al.
Orphanet Journal of Rare Diseases, 2022
Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.
Darling A et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2017
Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
Hayflick SJ et al.
The New England Journal of Medicine, 2003
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.
Zhou B et al.
Nature Genetics, 2001
Select a paper to view details